PERITI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.593
AS - Asia 4.276
EU - Europa 4.248
SA - Sud America 500
OC - Oceania 111
AF - Africa 87
Continente sconosciuto - Info sul continente non disponibili 64
Totale 15.879
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.486
RU - Federazione Russa 1.700
CN - Cina 1.243
SG - Singapore 1.158
IT - Italia 748
HK - Hong Kong 564
KR - Corea 519
IE - Irlanda 493
BR - Brasile 404
VN - Vietnam 370
SE - Svezia 316
UA - Ucraina 259
DE - Germania 246
FI - Finlandia 165
IN - India 156
FR - Francia 151
AU - Australia 108
GB - Regno Unito 90
JP - Giappone 72
CA - Canada 68
TR - Turchia 42
JO - Giordania 37
AR - Argentina 36
NG - Nigeria 25
BD - Bangladesh 21
MX - Messico 19
ES - Italia 18
PE - Perù 16
ZA - Sudafrica 15
IQ - Iraq 14
PL - Polonia 14
EC - Ecuador 13
NL - Olanda 12
CI - Costa d'Avorio 10
PK - Pakistan 10
BJ - Benin 9
ID - Indonesia 9
SC - Seychelles 9
UZ - Uzbekistan 9
UY - Uruguay 8
VE - Venezuela 8
CH - Svizzera 7
TW - Taiwan 7
CL - Cile 6
CO - Colombia 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
MA - Marocco 5
AZ - Azerbaigian 4
DK - Danimarca 4
OM - Oman 4
AL - Albania 3
BE - Belgio 3
BG - Bulgaria 3
DZ - Algeria 3
ET - Etiopia 3
JM - Giamaica 3
KE - Kenya 3
LT - Lituania 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
PS - Palestinian Territory 3
PY - Paraguay 3
TH - Thailandia 3
AM - Armenia 2
AT - Austria 2
GR - Grecia 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LY - Libia 2
NP - Nepal 2
PA - Panama 2
PH - Filippine 2
AP - ???statistics.table.value.countryCode.AP??? 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
NI - Nicaragua 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 15.815
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.719
Singapore 831
Seoul 502
Dublin 492
Hefei 488
Chandler 476
Jacksonville 471
Hong Kong 441
Ashburn 413
Fairfield 353
San Jose 188
Milan 167
Cambridge 158
Woodbridge 147
Los Angeles 140
The Dalles 140
Ho Chi Minh City 139
Buffalo 129
Seattle 125
Wilmington 125
Houston 119
Lauterbourg 118
Beijing 116
Melbourne 99
Mumbai 92
Hanoi 90
Princeton 86
Rome 81
Boardman 78
Tokyo 70
Boston 65
Helsinki 55
Kent 53
Lawrence 51
New York 50
Dallas 47
Moscow 47
Medford 45
Ann Arbor 43
Altamura 42
Munich 42
Shanghai 41
São Paulo 36
Turin 27
San Diego 23
Bengaluru 22
Abuja 21
Bologna 21
Naples 21
Turku 19
Norwalk 18
West Jordan 18
Auburn Hills 17
Florence 17
Guangzhou 17
Pune 17
Tianjin 17
Figino 15
Haiphong 15
Orem 15
Da Nang 14
Hillsboro 14
Toronto 13
Frankfurt am Main 12
Izmir 12
Lima 12
Chennai 11
Genoa 11
Paris 11
Abidjan 10
Brooklyn 10
Montreal 10
Verona 10
Andover 9
Brasília 9
Cotonou 9
Palermo 9
Warsaw 9
Baghdad 8
Biên Hòa 8
Dearborn 8
Frankfurt Am Main 8
London 8
Venice 8
Barnet 7
Denver 7
Dhaka 7
Phoenix 7
Redondo Beach 7
Redwood City 7
Rio de Janeiro 7
Tashkent 7
Yubileyny 7
Belo Horizonte 6
Bern 6
Charlotte 6
Council Bluffs 6
Iksan 6
Johannesburg 6
Manchester 6
Totale 9.878
Salva come PNG Salva come JPEG
Nome #
[Medical therapy of malignant melanoma] 239
Bacillus subtilis spores as a natural pro-host oral agent. Preliminary data in children. 181
Chromosomal characterization of methotrexate-resistant human T-lymphoblast leukemia cells (CCRF-CEM) with impaired polyglutamylation. 177
5-methyltetrahydrofolate (MeTHF) enhances fluoropyrimidine cytotoxicity against human leukemia cells in vitro 168
Adverse effects of macrolide antibacterials. 166
In vitro brodimoprim activity on nosocomial bacterial strains. 164
Antimicrobial prophylaxis in orthopaedic surgery: the role of teicoplanin. 159
[Plasma and tissue antibiotic concentrations: what is their prognostic value?] 157
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or with levamisole (LEV) or interferon alpha2a (IFN alpha2a). 155
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or combined with levamisole (LEV) or interferon alpha2a (IFN alpha2a). Preliminary toxicological results of a multicenter study of the Gruppo Oncologico-Chirurgico Cooperativo Italiano (GOCCI) 153
The penetration of intramuscular cefotetan disodium into human extravascular fluid and maternal milk secretion. 153
Antimicrobial prophylaxis in prosthetic joint implant surgery: a comparative multicenter trial between teicoplanin and cefazolin 152
[Antibiotic prophylaxis of postoperative infection in orthopedics. Results of an epidemiologic survey in Italy conducted by the Journal of Chemotherapy] 151
Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation. 151
Ofloxacin concentrations in human inflamed pericoronal tissue after oral administration. 151
Antimicrobial chemoimmunoprophylaxis in colorectal surgery with cefotetan and thymostimulin: prospective, controlled multicenter study. Italian Study Group on Antimicrobial Prophylaxis in Abdominal Surgery. 150
Phase I clinical trial of a new alkylating agent, PTT-119 148
Pharmacokinetics and endocrine effects of leuprolide depot in advanced prostatic cancer: a dose-response analysis 148
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil and l-folinic acid alone or combined with levamisole or interferon-alfa2a. Preliminary toxicological results of a multicenter study of the Italian Cooperative Oncological-Surgical Group (GOCCI) 146
Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci. 146
Clinical chemotherapeutic evaluation of fosfomycin plus amoxicillin (co-fosfolactamine): a prospective double-blind clinical trial. 146
Comparative pharmacokinetic evaluation of ceftriaxone and cefotaxime in coincidence for short-term antimicrobial prophylaxis in surgery 146
Biochemical modulation of fluoropyrimidines by antifolates and folates in an in vitro model of human leukemia. 145
Amikacin in obstetric, gynecologic, and neonatal infections: laboratory and clinical studies. 145
Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells. 143
A randomized multicenter study comparing 5-fluorouracil (5-FU) and l-folinic acid (L-LV) alone or with levamisole (LEV) or interferon alpha2a (IFNalpha2a) as adjuvant therapy for colorectal cancer 142
Comparative in vitro activity of ciprofloxacin against methicillin-resistant staphylococci 140
Efficacy of 3-(p-fluorofenyl)-L-alanyl-3-m-bis(2-chloroethyl)amino-phenyl-L-methionine ethoxy HCl (PTT-119) on human leukemia cell lines 140
Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review. 139
Ciprofloxacin inhibition of cefoxitin betalactamase induction in an Enterobacter cloacae strain. 138
Effect of the l and d stereoisomers of 5-formyltetrahydrofolate (LV) and 5-methytetrahydrofolate (5-CH3-H4PteGlu) on fluoropyrimidine cytotoxicity in human leukemic CCRF-CEM cells 137
PHASE II TRIAL OF 5-FLUOROURACIL AND THE NATURAL L-ISOMER OF FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL CARCINOMA. 136
Combination chemotherapy with cyclophosphamide, fluorouracil, and either epirubicin or mitoxantrone: a comparative randomized multicenter study in metastatic breast carcinoma. 136
Clinical pharmacokinetics of depot leuprorelin. 135
Human pharmacokinetic and pharmacodynamic profiles of leuprorelin acetate depot in prostatic cancer patients. 135
Tissue distribution of antimicrobial drugs. 135
Perioperative chemotherapy in thet reatment of carcinoma of the uterine cervix 135
Pharmacokinetics of oral medroxyprogesterone acetate at moderate doses. 134
Pharmacokinetics and blister fluid penetration of ticarcillin/clavulanate in adults 134
Phase II study of 5-FU plus 6-S-leucovorin (6S-LV) in advanced colorectal cancer 133
Phase I trial of a novel alkylating agent 132
Oral medroxyprogesterone acetate pharmacokinetics: results in a group of patients during a controlled clinical trial on stage I endometrial carcinoma. 132
Adjuvant chemotherapy with 5-fluorouracil (5-FU) and folinic acid (L-LV) for colorectal carcinoma: preliminary results of a randomized multicenter study of the Gruppo Cooperativo Oncologico Tosco-Umbro (GCOTU) 131
Moxalactam pharmacokinetics in healthy volunteers and patients with renal insufficiency. 131
Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM 130
Beta-lactamase evaluation of the amoxycillin-clavulanate association. 130
Pharmacokinetics and blister fluid penetration of brodimoprim in adults. 130
Pharmacokinetics of roxithromycin in renal and hepatic failure and drug interactions. 130
Preliminary results of a phase II multicenter study on the clinical efficacy and safety to the LH-RH analog leuprolide in the treatment of prostatic carcinoma 128
Penetration of cefotetan into suction skin blister fluid and tissue homogenates in patients undergoing abdominal surgery. 128
Anandron (RU 23908) in metastatic prostate cancer: preliminary results of a multicentric Italian study. 128
Chemoresistance to fosfomycin: a bacteriological study. 128
Does surgical prophylaxis with teicoplanin constitute a therapeutic advance? 127
Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen. 126
Comparative in vitro evaluation of the antimicrobial activity of flurithromycin by means of the MS-2 Abbott Research System. 125
Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis. 125
Leuprorelin acetate depot in advanced prostatic cancer: a phase II multicentre trial. 125
High dose fosfomycin: indications, tolerance and pharmacokinetics. 125
A comparison of the prophylactic use of teicoplanin or cefazolin in the prevention of infections complications of hip and knee prosthesis insertion 125
New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock. 124
Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery. 124
Prophylactic chemotherapy with fosfomycin trometamol salt during transurethral prostatic surgery: a controlled multicenter clinical trial. 122
Tissue distribution of cefotetan in patients with Crohn's disease. 122
Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin 121
First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer. 121
Clinical pharmacokinetics of cefpodoxime proxetil in older patients 120
In vitro effects of brodimoprim on human polymorphonuclear leukocyte functions. Preliminary results 120
The suction blister technique as a tool in antimicrobial drug pharmacokinetics. 120
Selecting antibacterial agents for the control of surgical infection: mini-review. 118
Efficacy of 3-(p-fluorofenyl)-L-alanyl-3-m-bis(2-chloroethyl)amino-phenyl-L-methionine ethoxy HCl (PTT-119) on human leukemia cell lines 115
Teicoplanin: its role as systemic burn therapy and as prophylaxis for orthopedic surgery 113
Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma. 113
Drug resistance in cancer: an overview of the clinical aspects. 113
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or combined with levamisole (LEV) or interferon alpha2a (IFN alpha2a). Preliminary toxicological results of a Multicenter Study of the Gruppo Oncologico-Chirurgico Cooperativo Italiano. 113
Impaired methotrexate polyglutamylation in a human leukemia cell line resistant to short-term, high-dose methotrexate. 112
Ceftizoxime concentrations in human aqueous humor following intravenous administration. 108
Comparative multicenter trial of teicoplanin versus cefazolin for antimicrobial prophylaxis in prosthetic joint implant surgery. Italian Study Group for Antimicrobial Prophylaxis in Orthopedic Surgery. 108
Single-dose ceftriaxone vs. multiple-dose cefotaxime antimicrobial prophylaxis in gynecologic and obstetrical surgery. Preliminary results of a multicenter propsective randomized study 108
Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin 105
Fluoropyrimidine-folate synergy in human leukemia-lymphoma cells in culture 105
Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma 103
Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part I). 103
Clinical pharmacokinetics and tissue penetration of teicoplanin 102
Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug. 102
Efficacy and safety of once-daily versus twice-daily administration of netilmicin in patients with urinary tract infections. 102
Comparative randomized multicenter study of cefotetan and cefazolin i.v. as antimicrobial prophylaxis in gynecological and obstetric surgery 102
Pharmacokinetics and endocrine effects of leuprolide depot 101
Single-dose cefotetan vs. multiple-dose cefoxitin--antimicrobial prophylaxis in colorectal surgery. Results of a prospective, multicenter, randomized study. 100
Sviluppo di linee cellulari leu¬cemiche umane resistenti al metotres¬sato (MTX). Ri¬sultati preliminari con un modello in studio in vitro alternativo 100
Single-dose ceftriaxone versus multi-dose cefotaxime as short-term antimicrobial prophylaxis in urologic surgery. Preliminary results of a multicenter prospective randomized study 99
Clinical pharmacokinetics and tissue penetration of teicoplanin. 99
Clinical pharmacokinetics of enoxacin in subjects with renal or hepatic impairment. 98
Clarithromycin: pharmacokinetics and pharmacodynamics 97
Single-dose ceftriaxone versus multi-dose cefotaxime antimicrobial prophylaxis in gynecologic and obstetrical surgery. Preliminary results of a multicenter prospective randomized study 96
Pharmacokinetics of 5-methyltetrahydrofolate in normal adults 96
Pharmacokinetics of azithromycin in patients with impaired hepatic function. 96
Pharmacokinetic drug interaction of macrolides 96
Penicilline, cefalosporine e altre beta-lattamine. 96
Phase I study of LY186641, a diarylsulfonylurea given on alternative weeks to patients with solid tumours 95
Concentration-effect relationship for antimicrobial drugs. 95
Totale 12.828
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.382
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022471 8 61 4 39 13 15 5 38 22 8 135 123
2022/20231.783 136 159 33 182 192 401 279 111 204 10 50 26
2023/2024689 44 81 147 32 55 121 10 149 4 22 10 14
2024/20254.992 183 543 254 704 1.362 746 60 215 298 117 220 290
2025/20265.399 666 962 760 539 439 134 545 223 289 162 85 595
2026/2027129 129 0 0 0 0 0 0 0 0 0 0 0
Totale 15.879